Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Alyssa C. Flint (16676029) (author)
Outros Autores:	Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
Publicado em:	2025
Assuntos:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados